European Heart Journal Advance Access originally published online on March 16, 2006
European Heart Journal 2006 27(8):893-894; doi:10.1093/eurheartj/ehi651
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems
Institute of Cardiology, University of Bologna, Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
* Corresponding author. Tel: +39 0 513 49858; fax: +39 0 513 44859. E-mail address: cardio1@med.unibo.it
This editorial refers to Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
by Heeringa et al., on page 949
| The first 10% of the full text of this article appears below. |
There is increasing awareness that management of atrial fibrillation (AF) and its complications (particularly strokes) constitutes an important burden for health care systems and a major clinical challenge. AF is the most common sustained arrhythmia, and detailed knowledge of its epidemiology is important both for provision of adequate care and for resource allocation. Available epidemiological studies have mainly focused on prevalence of AF. Important frequency variations have been recorded, often linked to different detection procedures.1 Most of what we know about the incidence of AF in the general population comes from two large North American studies and a single study from Britain mostly regarding hospitalized patients.1 Thus, the new population-based cohort study by Herringa et al.2
Acknowledgement
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
- Jan Heeringa, Deirdre A.M. van der Kuip, Albert Hofman, Jan A. Kors, Gerard van Herpen, Bruno H.Ch. Stricker, Theo Stijnen, Gregory Y.H. Lip, and Jacqueline C.M. Witteman
EHJ 2006 27: 949-953.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
C. Martignani, I. Diemberger, M. Biffi, C. Valzania, M. Bertini, G. Domenichini, and G. Boriani Atrial fibrillation ablation: beyond electro-mechanical matters Eur. Heart J., November 2, 2008; 29(22): 2818 - 2819. [Full Text] [PDF] |
||||
![]() |
C. Martignani, I. Diemberger, M. Biffi, C. Valzania, M. Bertini, and G. Boriani How to assess the efficacy of catheter ablation of atrial fibrillation? Eur. Heart J., September 1, 2008; 29(17): 2183 - 2184. [Full Text] [PDF] |
||||
![]() |
H. Aslan, O. Turgut, K. Yalta, M. B. Yilmaz, R. Ozdemir, N. Ermis, A. T. Sezgin, E. Yetkin, I. Tandogan, and A. Yilmaz Coronary Collateral Circulation: Any Effect on P-Wave Dispersion? Angiology, August 1, 2008; 59(4): 448 - 453. [Abstract] [PDF] |
||||
![]() |
A. Struthers and C. Lang The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney Eur. Heart J., July 2, 2007; 28(14): 1678 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heeringa, D. A. M. van der Kuip, A. Hofman, J. A. Kors, F. J. A. van Rooij, G. Y. H. Lip, and J. C. M. Witteman Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study Arch Intern Med, February 26, 2007; 167(4): 382 - 387. [Abstract] [Full Text] [PDF] |
||||


